Select a Community
Are you sure you want to trigger topic in your Anconeus AI algorithm?
You are done for today with this topic.
Would you like to start learning session with this topic items scheduled for future?
| # | Code | QID |
Subspecialty
|
Topic
|
Complexity
|
Importance
|
|---|---|---|---|---|---|---|
| 301 | M1.BC.17.4707 | 108452 |
Biochemistry
|
Lysosome |
M 1
|
C
|
| 302 | M1.ON.16.4699 | 108390 |
Oncology
|
Parathyroid Adenoma |
M 1
|
C
|
| 303 | M1.CV.13.40 | 100556 |
Cardiovascular
|
Congestive Heart Failure |
M 1
|
C
|
| 304 | M1.MC.17.4796 | 109170 |
Microbiology
|
Mycobacterium Tuberculosis |
M 2
|
C
|
| 305 | M1.CV.17.4867 | 109657 |
Cardiovascular
|
Myocardial Infarction |
M 4
|
C
|
| 306 | M1.ST.17.4738 | 108639 |
Stats
|
Statistical Distribution |
M 1
|
C
|
| 307 | M1.ST.17.4869 | 109852 |
Stats
|
Statistical Distribution |
M 1
|
C
|
| 308 | M1.BC.15.74 | 106624 |
Biochemistry
|
Amino Acid Catabolism |
M 1
|
C
|
| 309 | M1.PL.15.75 | 106790 |
Respiratory
|
Asthma |
M 1
|
C
|
| 310 | M1.ST.17.4766 | 109090 |
Stats
|
Statistical Measures |
M 1
|
C
|
| 311 | M1.CV.17.4765 | 109033 |
Cardiovascular
|
Baroreceptors and Chemoreceptors |
M 3
|
C
|
| 312 | M1.NE.17.4695 | 107914 |
Neurology
|
Cranial Nerves |
M 1
|
C
|
| 313 | M1.NE.17.4756 | 108927 |
Neurology
|
Cranial Nerves |
M 1
|
C
|
| 314 | M1.NE.17.4798 | 109252 |
Neurology
|
Cranial Nerves |
M 1
|
C
|
| 315 | M1.EC.17.4800 | 109333 |
Endocrine
|
Diabetes Drugs |
M 4
|
C
|
| 316 | M1.EC.17.4698 | 108199 |
Endocrine
|
Diabetes Drugs |
M 3
|
C
|
| 317 | M1.EC.17.4698 | 108200 |
Endocrine
|
Diabetes Drugs |
M 3
|
C
|
| 318 | M1.EC.17.4799 | 109305 |
Endocrine
|
Diabetes Drugs |
M 3
|
C
|
| 319 | M1.BC.17.4695 | 107983 |
Biochemistry
|
Water Soluble Vitamins |
M 1
|
C
|
| 320 | M1.BC.17.4695 | 107987 |
Biochemistry
|
Water Soluble Vitamins |
M 1
|
C
|
| 321 | M1.RL.15.4671 | 107160 |
Renal
|
Nephrotic Syndrome |
M 4
|
C
|
| 322 | M1.BC.15.72 | 106509 |
Biochemistry
|
Chromosomal Diseases |
M 2
|
C
|
| 323 | M1.CV.13.102 | 100618 |
Cardiovascular
|
Myocardial Infarction |
M 2
|
C
|
| 324 | M1.CV.13.35 | 100551 |
Cardiovascular
|
Myocardial Infarction |
M 1
|
C
|
| 325 | M1.PL.12.7 | 100810 |
Respiratory
|
Asthma |
M 1
|
C
|
| 326 | M1.NE.14.41 | 106262 |
Neurology
|
Cranial Nerves |
M 2
|
C
|
| 327 | M1.MC.15.75 | 106714 |
Microbiology
|
Hepatitis B Virus |
M 1
|
C
|
| 328 | M1.MC.15.75 | 106730 |
Microbiology
|
Hepatitis B Virus |
M 1
|
C
|
| 329 | M1.PH.15.75 | 106843 |
Pharmacology
|
Sympathomimetics |
M 1
|
C
|
| 330 | M1.PY.15.27 | 107036 |
Psychiatry
|
Signs and Symptoms of Drug Abuse (by Drug) |
M 3
|
C
|
| 331 | M1.ST.17.4707 | 108449 |
Stats
|
Bias |
M 1
|
C
|
| 332 | M1.CV.17.4754 | 108871 |
Cardiovascular
|
Cardiomyopathies |
M 1
|
C
|
| 333 | M1.HE.17.4695 | 107976 |
Hematology
|
Sickle Cell Anemia |
M 4
|
C
|
| 334 | M1.PY.17.4799 | 109318 |
Psychiatry
|
Other Eating Disorders |
M 2
|
C
|
| 335 | M1.CV.17.4698 | 108177 |
Cardiovascular
|
Antiarrhythmics |
M 3
|
C
|
| 336 | M1.CV.17.4754 | 108713 |
Cardiovascular
|
Valvular Disease |
M 2
|
C
|
| 337 | M1.PH.17.4870 | 109824 |
Pharmacology
|
Poisons and Treatments |
M 3
|
C
|
| 338 | M1.CV.17.4798 | 109209 |
Cardiovascular
|
Antiarrhythmics |
M 1
|
C
|
| 339 | M1.CV.17.4798 | 109221 |
Cardiovascular
|
Antiarrhythmics |
M 3
|
C
|
| 340 | M1.PH.17.4722 | 108519 |
Pharmacology
|
Poisons and Treatments |
M 3
|
C
|
| 341 | M1.PH.17.4767 | 109087 |
Pharmacology
|
Poisons and Treatments |
M 3
|
C
|
| 342 | M1.PH.17.4798 | 109228 |
Pharmacology
|
Poisons and Treatments |
M 2
|
C
|
| 343 | M1.NE.17.4817 | 109388 |
Neurology
|
Ischemic Stroke |
M 2
|
C
|
| 344 | M1.NE.17.4817 | 109389 |
Neurology
|
Ischemic Stroke |
M 3
|
C
|
| 345 | M1.NE.17.0 | 109554 |
Neurology
|
Ischemic Stroke |
M 2
|
C
|
| 346 | M1.PL.16.70 | 100873 |
Respiratory
|
Cystic Fibrosis |
M 1
|
C
|
| 347 | M1.PY.15.11281403 | 107073 |
Psychiatry
|
Personality Disorders |
M 2
|
C
|
| 348 | M1.RL.17.4717 | 108496 |
Renal
|
Nephritic Syndrome |
M 1
|
C
|
| 349 | M1.RL.17.4753 | 108861 |
Renal
|
Nephritic Syndrome |
M 1
|
C
|
| 350 | M1.RL.17.4798 | 109195 |
Renal
|
Nephrotic Syndrome |
M 1
|
C
|
| 351 | M1.MC.17.4754 | 108943 |
Microbiology
|
Opportunistic Mycoses |
M 3
|
C
|
| 352 | M1.MC.17.4754 | 108944 |
Microbiology
|
Opportunistic Mycoses |
M 1
|
C
|
| 353 | M1.ON.17.4753 | 108895 |
Oncology
|
Lung Cancer |
M 1
|
C
|
| 354 | M1.MC.17.4799 | 109296 |
Microbiology
|
Opportunistic Mycoses |
M 2
|
C
|
| 355 | M1.EC.17.4800 | 109276 |
Endocrine
|
Diabetes Mellitus |
M 3
|
C
|
| 356 | M1.EC.17.4817 | 109401 |
Endocrine
|
Diabetes Mellitus |
M 1
|
C
|
| 357 | M1.EC.17.4713 | 108484 |
Endocrine
|
Graves Disease |
M 1
|
C
|
| 358 | M1.PH.17.4799 | 109355 |
Pharmacology
|
Drug Reactions and Side Effects |
M 3
|
C
|
| 359 | M1.PH.17.4817 | 109408 |
Pharmacology
|
Drug Reactions and Side Effects |
M 1
|
C
|
| 360 | M1.PH.17.4799 | 109315 |
Pharmacology
|
Drug Reactions and Side Effects |
M 2
|
C
|
| 361 | M1.PH.17.4707 | 108437 |
Pharmacology
|
Drug Reactions and Side Effects |
M 3
|
C
|
| 362 | M1.ON.17.4720 | 108513 |
Oncology
|
Primary Brain Tumors |
M 1
|
C
|
| 363 | M1.ON.17.4868 | 109807 |
Oncology
|
Primary Brain Tumors |
M 1
|
C
|
| 364 | M1.NE.17.4867 | 109621 |
Neurology
|
Opiates |
M 3
|
C
|
| 365 | M1.BC.17.4708 | 108476 |
Biochemistry
|
Chromosomal Diseases |
M 2
|
C
|
| 366 | M1.BC.17.4753 | 108820 |
Biochemistry
|
Chromosomal Diseases |
M 2
|
C
|
| 367 | M1.PL.17.4798 | 109193 |
Respiratory
|
Sarcoidosis |
M 2
|
C
|
| 368 | M1.PL.14.134 | 100937 |
Respiratory
|
Asthma |
M 2
|
C
|
| 369 | M1.NE.17.4768 | 109061 |
Neurology
|
Eye Movement |
M 1
|
C
|
| 370 | M1.NE.17.4727 | 108581 |
Neurology
|
Eye Movement |
M 2
|
C
|
| 371 | M1.CV.17.4697 | 108146 |
Cardiovascular
|
Atrioventricular (AV) Heart Block |
M 2
|
C
|
| 372 | M1.CV.17.4754 | 108873 |
Cardiovascular
|
Atrioventricular (AV) Heart Block |
M 2
|
C
|
| 373 | M1.CV.17.4753 | 108858 |
Cardiovascular
|
Antianginal Therapy |
M 4
|
C
|
| 374 | M1.IM.17.4867 | 109601 |
Immunology
|
Bruton Agammaglobulinemia |
M 1
|
C
|
| 375 | M1.MK.17.4723 | 108533 |
MSK
|
Osteoporosis |
M 1
|
C
|
| 376 | M1.BC.17.4774 | 109106 |
Biochemistry
|
Fat Soluble Vitamins |
M 2
|
C
|
| 377 | M1.RL.17.4869 | 109765 |
Renal
|
Nephrolithiasis |
M 1
|
C
|
| 378 | M1.PY.17.4872 | 109905 |
Psychiatry
|
Signs and Symptoms of Drug Abuse (by Drug) |
M 3
|
C
|
| 379 | M1.PY.17.4800 | 109275 |
Psychiatry
|
Signs and Symptoms of Drug Abuse (by Drug) |
M 1
|
C
|
| 380 | M1.PY.17.4755 | 108717 |
Psychiatry
|
Signs and Symptoms of Drug Abuse (by Drug) |
M 1
|
C
|
| 381 | M1.MC.17.4721 | 108514 |
Microbiology
|
Hepatitis B Virus |
M 2
|
C
|
| 382 | M1.MC.17.4723 | 108522 |
Microbiology
|
HIV |
M 1
|
C
|
| 383 | M1.IM.17.4869 | 109746 |
Immunology
|
Hypersensitivity |
M 2
|
C
|
| 384 | M1.IM.17.4767 | 109089 |
Immunology
|
Hypersensitivity |
M 2
|
C
|
| 385 | M1.MC.17.4799 | 109201 |
Microbiology
|
HIV |
M 2
|
C
|
| 386 | M1.MC.17.4800 | 109274 |
Microbiology
|
HIV |
M 2
|
C
|
| 387 | M1.PH.17.4799 | 109316 |
Pharmacology
|
Sympathomimetics |
M 4
|
C
|
| 388 | M1.PH.17.4754 | 108966 |
Pharmacology
|
Sympathomimetics |
M 1
|
C
|
| 389 | M1.IM.17.4799 | 109306 |
Immunology
|
Innate Immune Response |
M 1
|
C
|
| 390 | M1.IM.17.4817 | 109393 |
Immunology
|
Transplant |
M 1
|
C
|
| 391 | M1.EB.17.4755 | 108881 |
Embryology
|
Branchial Apparatus |
M 1
|
C
|
| 392 | M1.EB.17.4867 | 109659 |
Embryology
|
Branchial Apparatus |
M 1
|
C
|
| 393 | M1.EB.17.4868 | 109728 |
Embryology
|
Branchial Apparatus |
M 2
|
C
|
| 394 | M1.BC.17.4755 | 108875 |
Biochemistry
|
DNA Repair |
M 1
|
C
|
| 395 | M1.BC.17.74 | 106637 |
Biochemistry
|
DNA Repair |
M 1
|
C
|
| 396 | M1.ST.17.4753 | 108828 |
Stats
|
Statistical Hypotheses and Error |
M 1
|
C
|
| 397 | M1.MC.12.7 | 101466 |
Microbiology
|
Clostridioides difficile |
M 1
|
C
|
| 398 | M1.PY.13.15 | 100015 |
Psychiatry
|
Ego Defenses |
M 1
|
C
|
| 399 | M1.PL.15.96 | 100899 |
Respiratory
|
Acute Respiratory Distress Syndrome (ARDS) |
M 2
|
C
|
| 400 | M1.NE.15.73 | 106599 |
Neurology
|
Sleep |
M 2
|
C
|
| 401 | M1.NE.15.4671 | 107139 |
Neurology
|
Sleep |
M 2
|
C
|
| 402 | M1.CV.17.4707 | 108428 |
Cardiovascular
|
Coarctation of the Aorta |
M 2
|
C
|
| 403 | M1.MK.17.4754 | 108946 |
MSK
|
Rheumatoid Arthritis |
M 2
|
C
|
| 404 | M1.ON.17.4723 | 108547 |
Oncology
|
Malignant Bone Tumors |
M 1
|
C
|
| 405 | M1.RL.17.4873 | 109979 |
Renal
|
Renal Artery Stenosis |
M 1
|
C
|
| 406 | M1.PL.17.4872 | 109934 |
Respiratory
|
Neonatal Respiratory Distress Syndrome |
M 4
|
C
|
| 407 | M1.HE.17.4752 | 108746 |
Hematology
|
Anticoagulants |
M 3
|
C
|
| 408 | M1.PY.17.4726 | 108572 |
Psychiatry
|
Personality Disorders |
M 2
|
C
|
| 409 | M1.PY.17.4727 | 108559 |
Psychiatry
|
Schizophrenia |
M 2
|
C
|
| 410 | M1.PY.17.4873 | 109990 |
Psychiatry
|
Personality Disorders |
M 1
|
C
|
| 411 | M1.PY.17.4869 | 109740 |
Psychiatry
|
Personality Disorders |
M 2
|
C
|
| 412 | M1.GI.17.4750 | 108689 |
Gastrointestinal
|
Cirrhosis and Portal Hypertension |
M 2
|
C
|
| 413 | M1.EC.17.4817 | 109402 |
Endocrine
|
Diabetic Ketoacidosis (DKA) |
M 2
|
C
|
| 414 | M1.PL.15.73 | 106572 |
Respiratory
|
Sleep Apnea |
M 2
|
C
|
| 415 | M1.CV.16.4671 | 107167 |
Cardiovascular
|
Valvular Disease |
M 2
|
C
|
| 416 | M1.ST.17.4738 | 108638 |
Stats
|
Measures of Association |
M 1
|
C
|
| 417 | M1.BC.17.4774 | 109102 |
Biochemistry
|
Glycolysis |
M 1
|
C
|
| 418 | M1.MC.17.4754 | 108932 |
Microbiology
|
Clostridioides difficile |
M 1
|
C
|
| 419 | M1.ON.15.4666 | 107111 |
Oncology
|
Malignant Breast Tumors |
M 2
|
C
|
| 420 | M1.ST.15.1 | 102719 |
Stats
|
Disease Prevention |
M 1
|
C
|
| 421 | M1.PL.13.142 | 100945 |
Respiratory
|
Sarcoidosis |
M 2
|
C
|
| 422 | M1.EC.17.4867 | 109634 |
Endocrine
|
Insulin and Glucagon |
M 3
|
C
|
| 423 | M1.EC.17.4695 | 107947 |
Endocrine
|
Insulin and Glucagon |
M 1
|
C
|
| 424 | M1.IM.17.4799 | 109190 |
Immunology
|
Immunosuppressive Drugs |
M 1
|
C
|
| 425 | M1.IM.17.4799 | 109191 |
Immunology
|
Immunosuppressive Drugs |
M 4
|
C
|
| 426 | M1.IM.17.4867 | 109627 |
Immunology
|
Antibodies |
M 1
|
C
|
| 427 | M1.IM.17.4867 | 109662 |
Immunology
|
Antibodies |
M 1
|
C
|
| 428 | M1.MC.17.4817 | 109391 |
Microbiology
|
CNS Infections: Protozoa |
M 3
|
C
|
| 429 | M1.IM.17.4873 | 109975 |
Immunology
|
Immunosuppressive Drugs |
M 3
|
C
|
| 430 | M1.IM.17.4868 | 109803 |
Immunology
|
Antibodies |
M 1
|
C
|
| 431 | M1.MK.17.4719 | 108506 |
MSK
|
Scaphoid Fracture |
M 4
|
C
|
| 432 | M1.MK.17.4722 | 108535 |
MSK
|
Achondroplasia |
M 1
|
C
|
| 433 | M1.PY.17.4698 | 108218 |
Psychiatry
|
Attention Deficit Hyperactivity Disorder |
M 2
|
C
|
| 434 | M1.RL.17.0 | 109444 |
Renal
|
Loop Diuretics |
M 1
|
C
|
| 435 | M1.PL.17.4874 | 109997 |
Respiratory
|
Pulmonary Hypertension |
M 2
|
C
|
| 436 | M1.PL.17.4799 | 109342 |
Respiratory
|
Asthma Drugs |
M 1
|
C
|
| 437 | M1.RL.17.4768 | 109082 |
Renal
|
ACE Inhibitors |
M 1
|
C
|
| 438 | M1.GI.17.4707 | 108457 |
Gastrointestinal
|
Wilson Disease |
M 2
|
C
|
| 439 | M1.CV.17.4753 | 108864 |
Cardiovascular
|
Antihypertensive Therapy |
M 4
|
C
|
| 440 | M1.PY.12.42 | 101706 |
Psychiatry
|
Tricyclic Antidepressants (TCAs) |
M 3
|
C
|
| 441 | M1.IM.14.61 | 100864 |
Immunology
|
Hypersensitivity |
M 1
|
C
|
| 442 | M1.MC.15.71 | 106497 |
Microbiology
|
HSV Type 2 |
M 1
|
C
|
| 443 | M1.MC.15.75 | 106724 |
Microbiology
|
HSV Type 1 |
M 2
|
C
|
| 444 | M1.MC.15.75 | 106737 |
Microbiology
|
HSV Type 1 |
M 1
|
C
|
| 445 | M1.MC.17.4707 | 108450 |
Microbiology
|
Systemic Mycoses |
M 2
|
C
|
| 446 | M1.BC.17.4740 | 108650 |
Biochemistry
|
Collagen |
M 2
|
C
|
| 447 | M1.BC.17.4708 | 108467 |
Biochemistry
|
RNA Processing |
M 1
|
C
|
| 448 | M1.EB.17.4765 | 109038 |
Embryology
|
Stages of Development |
M 4
|
C
|
| 449 | M1.EB.17.4753 | 108841 |
Embryology
|
Stages of Development |
M 1
|
C
|
| 450 | M1.MC.15.74 | 106673 |
Microbiology
|
Epstein-Barr Virus |
M 1
|
C
|